Clinical Trials Directory

Trials / Unknown

UnknownNCT05534139

Clinicopathological MRI and CSF Correlates in Huntington's Disease.

Clinicopathological MRI and CSF Correlates of Iron Accumulation, Neurodegeneration and Neuroinflammation in Huntington's Disease.

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Leiden University Medical Center · Academic / Other
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Accepted

Summary

In this study the investigators will link brain iron levels obtained from quantitative susceptibility maps of HD patients with specific and well-known clinical CSF markers for iron accumulation, neurodegeneration and neuroinflammation. The relationship between iron accumulation and neuroinflammation, and the clinical and genetic characteristics of HD will be investigated. This will provide an important basis for the evaluation of brain iron levels as an imaging biomarker for disease state in HD and their relationship with the salient pathomechanisms of the disease.

Detailed description

This investigator-initiated, single-site cross-sectional study looks at iron accumulation using 7T MR-imaging, CSF and blood. This will be achieved in a two-day visit involving clinical assessments, MRI-scanning of the brain, followed by a lumbar puncture the next day, after overnight fasting. Sixty-five volunteers with HD and 25 volunteers without HD will be included. Of these 65 volunteers with HD, 25 will be premanifest, 20 early manifest and 20 moderate manifest, in order to cover the wide-spectrum of Huntington's Disease.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST7T MRI-scanMRI-scanning of the brain using a 7T-MRI scanner
DIAGNOSTIC_TESTCSF collection via lumbar punctureCSF is collected by doing a lumbar puncture
DIAGNOSTIC_TESTBlood withdrawalBlood is collected by doing a blood withdrawal
DIAGNOSTIC_TESTClinical measuresUHDRS-Total motor score, UHDRS-short problem behaviour assessment, UHDRS-Cognitive assessments

Timeline

Start date
2021-08-11
Primary completion
2023-08-31
Completion
2024-08-31
First posted
2022-09-09
Last updated
2022-09-09

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05534139. Inclusion in this directory is not an endorsement.